company background image
002424 logo

Guizhou Bailing Group Pharmaceutical SZSE:002424 Stock Report

Last Price

CN¥4.01

Market Cap

CN¥5.5b

7D

-2.0%

1Y

-52.2%

Updated

25 Nov, 2024

Data

Company Financials

Guizhou Bailing Group Pharmaceutical Co., Ltd.

SZSE:002424 Stock Report

Market Cap: CN¥5.5b

002424 Stock Overview

Guizhou Bailing Group Pharmaceutical Co., Ltd. More details

002424 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Guizhou Bailing Group Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Guizhou Bailing Group Pharmaceutical
Historical stock prices
Current Share PriceCN¥4.01
52 Week HighCN¥8.80
52 Week LowCN¥2.98
Beta0.46
11 Month Change4.97%
3 Month Change20.78%
1 Year Change-52.21%
33 Year Change-32.94%
5 Year Change-51.45%
Change since IPO-5.02%

Recent News & Updates

There's No Escaping Guizhou Bailing Group Pharmaceutical Co., Ltd.'s (SZSE:002424) Muted Revenues Despite A 26% Share Price Rise

Nov 13
There's No Escaping Guizhou Bailing Group Pharmaceutical Co., Ltd.'s (SZSE:002424) Muted Revenues Despite A 26% Share Price Rise

Does Guizhou Bailing Group Pharmaceutical (SZSE:002424) Have A Healthy Balance Sheet?

Oct 24
Does Guizhou Bailing Group Pharmaceutical (SZSE:002424) Have A Healthy Balance Sheet?

Why Investors Shouldn't Be Surprised By Guizhou Bailing Group Pharmaceutical Co., Ltd.'s (SZSE:002424) Low P/S

Aug 15
Why Investors Shouldn't Be Surprised By Guizhou Bailing Group Pharmaceutical Co., Ltd.'s (SZSE:002424) Low P/S

Recent updates

There's No Escaping Guizhou Bailing Group Pharmaceutical Co., Ltd.'s (SZSE:002424) Muted Revenues Despite A 26% Share Price Rise

Nov 13
There's No Escaping Guizhou Bailing Group Pharmaceutical Co., Ltd.'s (SZSE:002424) Muted Revenues Despite A 26% Share Price Rise

Does Guizhou Bailing Group Pharmaceutical (SZSE:002424) Have A Healthy Balance Sheet?

Oct 24
Does Guizhou Bailing Group Pharmaceutical (SZSE:002424) Have A Healthy Balance Sheet?

Why Investors Shouldn't Be Surprised By Guizhou Bailing Group Pharmaceutical Co., Ltd.'s (SZSE:002424) Low P/S

Aug 15
Why Investors Shouldn't Be Surprised By Guizhou Bailing Group Pharmaceutical Co., Ltd.'s (SZSE:002424) Low P/S

Guizhou Bailing Group Pharmaceutical Co., Ltd. (SZSE:002424) Stock's 32% Dive Might Signal An Opportunity But It Requires Some Scrutiny

May 10
Guizhou Bailing Group Pharmaceutical Co., Ltd. (SZSE:002424) Stock's 32% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Shareholder Returns

002424CN PharmaceuticalsCN Market
7D-2.0%-1.5%-2.1%
1Y-52.2%-9.4%2.8%

Return vs Industry: 002424 underperformed the CN Pharmaceuticals industry which returned -9.4% over the past year.

Return vs Market: 002424 underperformed the CN Market which returned 2.8% over the past year.

Price Volatility

Is 002424's price volatile compared to industry and market?
002424 volatility
002424 Average Weekly Movement6.3%
Pharmaceuticals Industry Average Movement7.4%
Market Average Movement8.4%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 002424 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 002424's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19996,582Min Niuwww.gzbl.com

Guizhou Bailing Group Pharmaceutical Co., Ltd. research, develops, produces, and sells medicines in China. The company provides medicines in the form of tablets, capsules, granules, syrups, powders, pills, tinctures, sprays, lotions, and cream for cardiovascular and cerebrovascular diseases, cough, cold, pediatric, and gynecologic diseases.

Guizhou Bailing Group Pharmaceutical Co., Ltd. Fundamentals Summary

How do Guizhou Bailing Group Pharmaceutical's earnings and revenue compare to its market cap?
002424 fundamental statistics
Market capCN¥5.50b
Earnings (TTM)-CN¥466.78m
Revenue (TTM)CN¥4.23b

1.3x

P/S Ratio

-11.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002424 income statement (TTM)
RevenueCN¥4.23b
Cost of RevenueCN¥1.87b
Gross ProfitCN¥2.36b
Other ExpensesCN¥2.83b
Earnings-CN¥466.78m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.34
Gross Margin55.82%
Net Profit Margin-11.04%
Debt/Equity Ratio51.4%

How did 002424 perform over the long term?

See historical performance and comparison